Skip to content
healthcare.dev

BRENZAVVY

NDC 82381-2174, Bexagliflozin, tablet, from TheracosBio, LLC.

Product NDC
82381-2174
Status
Listed
Labeler
TheracosBio, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214373
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82381-2174 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BEXAGLIFLOZIN20 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
82381-2174-18238121740130 TABLET in 1 BOTTLE (82381-2174-1)
82381-2174-28238121740290 TABLET in 1 BOTTLE (82381-2174-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3cdf28fc-4194-4ad6-aa03-c9eaa68da83e

Use it

Look up 82381-2174 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82381-2174 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82381-2174. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.